Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iodine-131 Anti-B1 Antibody and BEAM with Stem Cell Transplant in Recurrent DLBCL
NCT00006695Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Apr 2000
- Primary completion
- Sep 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab in diffuse large B-cell lymphoma (DLBCL), sponsored by University of Nebraska. Started Apr 2000; status: completed.
02
Drugs
tositumomab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00006695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006695.